CA2154689A1 - Composition immunotherapeutique amelioree - Google Patents

Composition immunotherapeutique amelioree

Info

Publication number
CA2154689A1
CA2154689A1 CA002154689A CA2154689A CA2154689A1 CA 2154689 A1 CA2154689 A1 CA 2154689A1 CA 002154689 A CA002154689 A CA 002154689A CA 2154689 A CA2154689 A CA 2154689A CA 2154689 A1 CA2154689 A1 CA 2154689A1
Authority
CA
Canada
Prior art keywords
immunotherapeutic composition
present
improved immunotherapeutic
improved
abort
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002154689A
Other languages
English (en)
Other versions
CA2154689C (fr
Inventor
Stanley J. Alkemade
Graeme Mcrae
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Telesta Therapeutics Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/CA1994/000054 external-priority patent/WO1994016727A1/fr
Publication of CA2154689A1 publication Critical patent/CA2154689A1/fr
Application granted granted Critical
Publication of CA2154689C publication Critical patent/CA2154689C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002154689A 1993-01-29 1994-01-28 Composition immunotherapeutique amelioree Expired - Lifetime CA2154689C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1165593A 1993-01-29 1993-01-29
US011,655 1993-01-29
PCT/CA1994/000054 WO1994016727A1 (fr) 1993-01-29 1994-01-28 Composition immunotherapeutique

Publications (2)

Publication Number Publication Date
CA2154689A1 true CA2154689A1 (fr) 1994-08-04
CA2154689C CA2154689C (fr) 2007-05-01

Family

ID=38051317

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002154689A Expired - Lifetime CA2154689C (fr) 1993-01-29 1994-01-28 Composition immunotherapeutique amelioree

Country Status (1)

Country Link
CA (1) CA2154689C (fr)

Also Published As

Publication number Publication date
CA2154689C (fr) 2007-05-01

Similar Documents

Publication Publication Date Title
DE69418183D1 (de) Immunotherapeutische zubereitung
EP0206529A3 (fr) Traitement de maladies orales
CA2132953A1 (fr) Anticorps monoclonaux monospecifiques des toxines ressemblant a la toxine shiga
DE3684305D1 (de) Antivirales immunotherapeutisches mittel und dessen herstellung.
EP1818343A3 (fr) Anticorps contre l'IL-12 humaine
DE69133516D1 (de) Behandlung von autoimmunkrankheiten durch orale verabreichung von autoantigenen
CA2117492A1 (fr) Antigene de voisinage supprimant des maladies immunitaires
CA2149329A1 (fr) Utilisation d'anticorps hybrides et radioisotopiques diriges contre l'antigene de restriction de la differenciation des lymphocytes b humains pour le traitement du lymphome b
GR3000495T3 (en) Use of beerdraff for the preparation of medicinal and cosmetic preparations
IL68350A0 (en) N-glycosylated carboxamide derivatives,their preparation and their use for the treatment of animals
NZ209635A (en) Pharmaceutical composition containing extract from microorganism and detoxified endotoxin
DE60236318D1 (de) Präparationen grampositiver bakterien zur behandlung von krankheiten mit immunfehlregulation
AU3549697A (en) Extracting particles produced by the treating of human or animal nails
CA2254682A1 (fr) Methode de traitement d'infections oculaires au moyen d'azithromycine
EP0308197A3 (fr) Méthode pour stimuler le système immunitaire
WO1999024077A3 (fr) Compositions et procedes d'administration ciblee de facteurs
NZ506681A (en) Disinfecting composition
KR890700353A (ko) 면역독소의 면역억제 기저 사람치료법
GB9425730D0 (en) Compounds
BG93298A (bg) Имуностимулиращи 6-арил-5,6-дихидроимидазо(2,1-в)тиазолови производни
HUP9902415A2 (hu) Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására
CA2109977A1 (fr) Vaccin giardia
CA2154689A1 (fr) Composition immunotherapeutique amelioree
DE69429521D1 (de) Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
HUP9900007A2 (hu) Készítmény baromfialom kezelésére

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20140128